Epidemiologic trends in head and neck cancer and aids in diagnosis

Oral and Maxillofacial Surgery Clinics of North America

Volumn 26, Issue 2, 2014, Pages 123-141

  Vigneswaran, Nadarajah ^a   Williams, Michelle D ^b  

^a UNIVERSITY OF TEXAS DENTAL BRANCH AT HOUSTON   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Diagnosis; Epidemiologic trends; Head and neck cancer; Squamous cell carcinomas

Indexed keywords

TUMOR MARKER;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION; COMPLICATION; DIAGNOSTIC IMAGING; HEAD AND NECK NEOPLASMS; HUMAN; INCIDENCE; MOUTH DISEASE; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PREDICTIVE VALUE; RISK FACTOR; TOBACCO DEPENDENCE;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSTIC IMAGING; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MOUTH DISEASES; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TOBACCO USE DISORDER; TUMOR MARKERS, BIOLOGICAL;

EID: 84899694808     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2014.01.001     Document Type: Review

References (69)

1. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108.
2. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009, 45(4-5):309-316.
3. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63(1):11-30.
4. Sturgis E.M., Cinciripini P.M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer 2007, 110(7):1429-1435.
5. Ramqvist T., Dalianis T. Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis 2010, 16(11):1671-1677.
6. Carvalho A.L., Nishimoto I.N., Califano J.A., et al. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005, 114(5):806-816.
7. Fakhry C., D'Souza G. Discussing the diagnosis of HPV-OSCC: common questions and answers. Oral Oncol 2013, 49(9):863-871.
8. Blot W.J., McLaughlin J.K., Winn D.M., et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988, 48(11):3282-3287.
9. Travasso C. Betel quid chewing is responsible for half of oral cancer cases in India, finds study. BMJ 2013, 347:f7536.
10. Rodu B., Jansson C. Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med 2004, 15(5):252-263.
11. Petti S., Masood M., Messano G.A., et al. Alcohol is not a risk factor for oral cancer in nonsmoking, betel quid non-chewing individuals. A meta-analysis update. Ann Ig 2013, 25(1):3-14.
12. Kreimer A.R., Clifford G.M., Boyle P., et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14(2):467-475.
13. Ang K.K., Harris J., Wheeler R., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. NEngl J Med 2010, 363(1):24-35.
14. Levitus M., Joenje H., de Winter J.P. The Fanconi anemia pathway of genomic maintenance. Cell Oncol 2006, 28(1-2):3-29.
15. Kutler D.I., Auerbach A.D., Satagopan J., et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 2003, 129(1):106-112.
16. Masserot C., Peffault de Latour R., Rocha V., et al. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation. Cancer 2008, 113(12):3315-3322.
17. Bessler M., Wilson D.B., Mason P.J. Dyskeratosis congenita. FEBS Lett 2010, 584(17):3831-3838.
18. Scheckenbach K., Wagenmann M., Freund M., et al. Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines. Klin Padiatr 2012, 224(3):132-138.
19. Vigneswaran N., Tilashalski K., Rodu B., et al. Tobacco use and cancer. A reappraisal. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995, 80(2):178-182.
20. Centers for Disease Control and Prevention (CDC) Human papillomavirus-associated cancers - United States, 2004-2008. MMWR Morb Mortal Wkly Rep 2012, 61:258-261.
21. Chen A.Y., Myers J.N. Cancer of the oral cavity. Dis Mon 2001, 47(7):275-361.
22. Ridge J.A., Glisson B.S., Lango M.N., et al. Head and neck tumors. Cancer management: a multidisciplinary approach, medical, surgical & radiation oncology 2011, 1-42. UBM Medica, Norwalk, CT. 14th edition. D.E. Haller, L.D. Wagman, K.A. Camphausen (Eds.).
23. Patel S.C., Carpenter W.R., Tyree S., et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. JClin Oncol 2011, 29(11):1488-1494.
24. Schantz S.P., Yu G.P. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. ArchOtolaryngol Head Neck Surg 2002, 128(3):268-274.
25. Shiboski C.H., Schmidt B.L., Jordan R.C. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005, 103(9):1843-1849.
26. Harris S.L., Kimple R.J., Hayes D.N., et al. Never-smokers, never-drinkers: unique clinical subgroup of young patients with head and neck squamous cell cancers. Head Neck 2010, 32(4):499-503.
27. Vargas H., Pitman K.T., Johnson J.T., et al. More aggressive behavior of squamous cell carcinoma of the anterior tongue in young women. Laryngoscope 2000, 110(10 Pt 1):1623-1626.
28. Sano D., Myers J.N. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 2007, 26(3-4):645-662.
29. Warnakulasuriya S., Johnson N.W., van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. JOral Pathol Med 2007, 36(10):575-580.
30. Caporaso N.E. Why precursors matter. Cancer Epidemiol Biomarkers Prev 2013, 22(4):518-520.
31. Napier S.S., Speight P.M. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. JOral Pathol Med 2008, 37(1):1-10.
32. Gillenwater A.M., Vigneswaran N., Fatani H., et al. Proliferative verrucous leukoplakia (PVL): recognition and differentiation from conventional leukoplakia and mimics!. Head Neck 2013, [Epub ahead of print].
33. Gillenwater A.M., Vigneswaran N., Fatani H., et al. Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!. Adv Anat Pathol 2013, 20(6):416-423.
34. Zain R.B., Ikeda N., Gupta P.C., et al. Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996. JOral Pathol Med 1999, 28(1):1-4.
35. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. JAm Acad Dermatol 2002, 46(2):207-214.
36. Lovas J.G., Harsanyi B.B., ElGeneidy A.K. Oral lichenoid dysplasia: a clinicopathologic analysis. Oral Surg Oral Med Oral Pathol 1989, 68(1):57-63.
37. Zhang L., Cheng X., Li Y., et al. High frequency of allelic loss in dysplastic lichenoid lesions. Lab Invest 2000, 80(2):233-237.
38. Epstein J.B., Guneri P., Boyacioglu H., et al. The limitations of the clinical oral examination in detecting dysplastic oral lesions and oral squamous cell carcinoma. JAm Dent Assoc 2012, 143(12):1332-1342.
39. Shin D., Vigneswaran N., Gillenwater A., et al. Advances in fluorescence imaging techniques to detect oral cancer and its precursors. Future Oncol 2010, 6(7):1143-1154.
40. Lingen M.W., Kalmar J.R., Karrison T., et al. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008, 44(1):10-22.
41. Speight P.M. Update on oral epithelial dysplasia and progression to cancer. Head Neck Pathol 2007, 1(1):61-66.
42. Mithani S.K., Mydlarz W.K., Grumbine F.L., et al. Molecular genetics of premalignant oral lesions. Oral Dis 2007, 13(2):126-133.
43. Zhang L., Poh C.F., Williams M., et al. Loss of heterozygosity (LOH) profiles-validated risk predictors for progression to oral cancer. Cancer Prev Res (Phila) 2012, 5(9):1081-1089.
44. Brennan M., Migliorati C.A., Lockhart P.B., et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 103(Suppl):S19.e11-S19.e12.
45. Arnaoutakis D., Bishop J., Westra W., et al. Recurrence patterns and management of oral cavity premalignant lesions. Oral Oncol 2013, 49(8):814-817.
46. Mehanna H.M., Rattay T., Smith J., et al. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck 2009, 31(12):1600-1609.
47. Meltzer C. Surgical management of oral and mucosal dysplasias: the case for laser excision. JOral Maxillofac Surg 2007, 65(2):293-295.
48. Saito T., Sugiura C., Hirai A., et al. Development ofsquamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg 2001, 30(1):49-53.
49. Wong S.J., Campbell B., Massey B., et al. Aphase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral Oncol 2013, 49(9):970-976.
50. Saba N., Hurwitz S.J., Kono S., et al. Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase 1b and pharmacokinetic study. Cancer Prev Res 2014, 7(3):283-291.
51. El-Mofty S.K., Patil S. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 101(3):339-345.
52. Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol 2010, 21(Suppl 7):vii89-vii92.
53. Tai S.K., Li W.Y., Chu P.Y., et al. Risks and clinical implications of perineural invasion in T1-2 oral tongue squamous cell carcinoma. Head Neck 2012, 34(7):994-1001.
54. Yuen A.P., Ho C.M., Chow T.L., et al. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck 2009, 31(6):765-772.
55. Sparano A., Weinstein G., Chalian A., et al. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 2004, 131(4):472-476.
56. Zhang T., Lubek J.E., Salama A., et al. Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters. JOral Maxillofac Surg 2014, 72(2):406-414.
57. Mohit-Tabatabai M.A., Sobel H.J., Rush B.F., et al. Relation of thickness of floor of mouth stage I and II cancers to regional metastasis. Am J Surg 1986, 152(4):351-353.
58. Chandler K., Vance C., Budnick S., et al. Muscle invasion in oral tongue squamous cell carcinoma as a predictor of nodal status and local recurrence: just as effective as depth of invasion?. Head Neck Pathol 2011, 5(4):359-363.
59. Brandwein-Gensler M., Teixeira M.S., Lewis C.M., et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005, 29(2):167-178.
60. Hinni M.L., Ferlito A., Brandwein-Gensler M.S., et al. Surgical margins in head and neck cancer: a contemporary review. Head Neck 2013, 35(9):1362-1370.
61. Slootweg P.J., Hordijk G.J., Schade Y., et al. Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. Oral Oncol 2002, 38(5):500-503.
62. Johnson J.T., Myers E.N., Bedetti C.D., et al. Cervical lymph node metastases. Incidence and implications of extracapsular carcinoma. Arch Otolaryngol 1985, 111(8):534-537.
63. Myers J.N., Greenberg J.S., Mo V., et al. Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 2001, 92(12):3030-3036.
64. Gruber G., Bonetti M., Nasi M.L., et al. Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI. JClin Oncol 2005, 23(28):7089-7097.
65. AJCC cancer staging manual 2009, Springer, New York. 7th edition. S.B. Edge, D.R. Byrd, C.C. Compton (Eds.).
66. Schache A.G., Liloglou T., Risk J.M., et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 2011, 17(19):6262-6271.
67. Duray A., Descamps G., Arafa M., et al. High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int J Oncol 2011, 39(1):51-59.
68. Rothenberg S.M., Ellisen L.W. The molecular pathogenesis of head and neck squamous cell carcinoma. JClin Invest 2012, 122(6):1951-1957.
69. Skinner H.D., Sandulache V.C., Ow T.J., et al. TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence. Clin Cancer Res 2012, 18(1):290-300.